110 related articles for article (PubMed ID: 23090772)
1. Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats.
McCarthy CA; Vinh A; Broughton BR; Sobey CG; Callaway JK; Widdop RE
Hypertension; 2012 Dec; 60(6):1531-7. PubMed ID: 23090772
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke.
McCarthy CA; Vinh A; Callaway JK; Widdop RE
Stroke; 2009 Apr; 40(4):1482-9. PubMed ID: 19246705
[TBL] [Abstract][Full Text] [Related]
3. Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats.
McCarthy CA; Vinh A; Miller AA; Hallberg A; Alterman M; Callaway JK; Widdop RE
PLoS One; 2014; 9(4):e95762. PubMed ID: 24752645
[TBL] [Abstract][Full Text] [Related]
4. PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a.
McCarthy CA; Rash LD; Chassagnon IR; King GF; Widdop RE
Neuropharmacology; 2015 Dec; 99():650-7. PubMed ID: 26320544
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 2 receptor agonists as therapies for ischemic stroke.
Dorrance AM
Hypertension; 2012 Dec; 60(6):1391-2. PubMed ID: 23090776
[No Abstract] [Full Text] [Related]
6. AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.
Li XC; Widdop RE
Br J Pharmacol; 2004 Jul; 142(5):821-30. PubMed ID: 15197103
[TBL] [Abstract][Full Text] [Related]
7. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage.
Min LJ; Mogi M; Tsukuda K; Jing F; Ohshima K; Nakaoka H; Kan-No H; Wang XL; Chisaka T; Bai HY; Iwanami J; Horiuchi M
Am J Hypertens; 2014 Aug; 27(8):1036-44. PubMed ID: 24572705
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.
Gelosa P; Pignieri A; Fändriks L; de Gasparo M; Hallberg A; Banfi C; Castiglioni L; Turolo L; Guerrini U; Tremoli E; Sironi L
J Hypertens; 2009 Dec; 27(12):2444-51. PubMed ID: 19680135
[TBL] [Abstract][Full Text] [Related]
9. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke.
Kobayashi T; Kawamata T; Shibata N; Okada Y; Kobayashi M; Hori T
J Neurotrauma; 2009 Dec; 26(12):2355-64. PubMed ID: 19604102
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective efficacy of subcutaneous insulin-like growth factor-I administration in normotensive and hypertensive rats with an ischemic stroke.
De Geyter D; Stoop W; Sarre S; De Keyser J; Kooijman R
Neuroscience; 2013 Oct; 250():253-62. PubMed ID: 23872393
[TBL] [Abstract][Full Text] [Related]
13. Post-stroke treatment with 17β-estradiol exerts neuroprotective effects in both normotensive and hypertensive rats.
Stoop W; De Geyter D; Verachtert S; Brouwers S; Verdood P; De Keyser J; Kooijman R
Neuroscience; 2017 Apr; 348():335-345. PubMed ID: 28257893
[TBL] [Abstract][Full Text] [Related]
14. Strategies to improve post-stroke behavioral recovery in aged subjects.
Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
[TBL] [Abstract][Full Text] [Related]
15. Opioids modulate post-ischemic progression in a rat model of stroke.
Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
[TBL] [Abstract][Full Text] [Related]
16. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
17. Cerebroprotective effects of red ginseng extract pretreatment against ischemia-induced oxidative stress and apoptosis.
Cheon SY; Cho KJ; Lee JE; Kim HW; Lee SK; Kim HJ; Kim GW
Int J Neurosci; 2013 Apr; 123(4):269-77. PubMed ID: 23240589
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the angiotensin II AT
Bennion DM; Jones CH; Dang AN; Isenberg J; Graham JT; Lindblad L; Domenig O; Waters MF; Poglitsch M; Sumners C; Steckelings UM
Clin Sci (Lond); 2018 Mar; 132(5):581-593. PubMed ID: 29500223
[TBL] [Abstract][Full Text] [Related]
19. Suramin reduces infarct volume in a model of focal brain ischemia in rats.
Kharlamov A; Jones SC; Kim DK
Exp Brain Res; 2002 Dec; 147(3):353-9. PubMed ID: 12428143
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Brouwers S; Smolders I; Massie A; Dupont AG
Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
